These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
585 related articles for article (PubMed ID: 27383586)
41. Reducing eIF4E-eIF4G interactions restores the balance between protein synthesis and actin dynamics in fragile X syndrome model mice. Santini E; Huynh TN; Longo F; Koo SY; Mojica E; D'Andrea L; Bagni C; Klann E Sci Signal; 2017 Nov; 10(504):. PubMed ID: 29114037 [TBL] [Abstract][Full Text] [Related]
42. Tau reduction attenuates autism-like features in Fmr1 knockout mice. Zhao S; Jiang X; Han L; Jiang Y; Wang Y; Meng J; Zhu X; Zhang X; Luo H; Zhang YW Mol Autism; 2023 Nov; 14(1):42. PubMed ID: 37936174 [TBL] [Abstract][Full Text] [Related]
43. Involvement of Phosphodiesterase 2A Activity in the Pathophysiology of Fragile X Syndrome. Maurin T; Melancia F; Jarjat M; Castro L; Costa L; Delhaye S; Khayachi A; Castagnola S; Mota E; Di Giorgio A; Servadio M; Drozd M; Poupon G; Schiavi S; Sardone L; Azoulay S; Ciranna L; Martin S; Vincent P; Trezza V; Bardoni B Cereb Cortex; 2019 Jul; 29(8):3241-3252. PubMed ID: 30137253 [TBL] [Abstract][Full Text] [Related]
44. Audiogenic Seizures in the Gonzalez D; Tomasek M; Hays S; Sridhar V; Ammanuel S; Chang CW; Pawlowski K; Huber KM; Gibson JR J Neurosci; 2019 Dec; 39(49):9852-9863. PubMed ID: 31666356 [TBL] [Abstract][Full Text] [Related]
45. Fragile X mental retardation protein modulates somatic D-type K Kalmbach BE; Brager DH J Neurophysiol; 2020 Dec; 124(6):1766-1773. PubMed ID: 32997566 [TBL] [Abstract][Full Text] [Related]
47. Absence of the Fragile X Mental Retardation Protein results in defects of RNA editing of neuronal mRNAs in mouse. Filippini A; Bonini D; Lacoux C; Pacini L; Zingariello M; Sancillo L; Bosisio D; Salvi V; Mingardi J; La Via L; Zalfa F; Bagni C; Barbon A RNA Biol; 2017 Nov; 14(11):1580-1591. PubMed ID: 28640668 [TBL] [Abstract][Full Text] [Related]
48. Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome. Centonze D; Rossi S; Mercaldo V; Napoli I; Ciotti MT; De Chiara V; Musella A; Prosperetti C; Calabresi P; Bernardi G; Bagni C Biol Psychiatry; 2008 May; 63(10):963-73. PubMed ID: 18028882 [TBL] [Abstract][Full Text] [Related]
49. Proteome profiling of the prefrontal cortex of Fmr1 knockout mouse reveals enhancement of complement and coagulation cascades. Gao MM; Shi H; Yan HJ; Long YS J Proteomics; 2023 Mar; 274():104822. PubMed ID: 36646274 [TBL] [Abstract][Full Text] [Related]
50. Selective Disruption of Metabotropic Glutamate Receptor 5-Homer Interactions Mimics Phenotypes of Fragile X Syndrome in Mice. Guo W; Molinaro G; Collins KA; Hays SA; Paylor R; Worley PF; Szumlinski KK; Huber KM J Neurosci; 2016 Feb; 36(7):2131-47. PubMed ID: 26888925 [TBL] [Abstract][Full Text] [Related]
51. Dysregulated metabotropic glutamate receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a mouse model of fragile X syndrome. Muddashetty RS; Kelić S; Gross C; Xu M; Bassell GJ J Neurosci; 2007 May; 27(20):5338-48. PubMed ID: 17507556 [TBL] [Abstract][Full Text] [Related]
52. FMRP has a cell-type-specific role in CA1 pyramidal neurons to regulate autism-related transcripts and circadian memory. Sawicka K; Hale CR; Park CY; Fak JJ; Gresack JE; Van Driesche SJ; Kang JJ; Darnell JC; Darnell RB Elife; 2019 Dec; 8():. PubMed ID: 31860442 [TBL] [Abstract][Full Text] [Related]
53. Persistent astrocyte activation in the fragile X mouse cerebellum. Pacey LK; Guan S; Tharmalingam S; Thomsen C; Hampson DR Brain Behav; 2015 Oct; 5(10):e00400. PubMed ID: 26516618 [TBL] [Abstract][Full Text] [Related]
54. Altered maturation of the primary somatosensory cortex in a mouse model of fragile X syndrome. Till SM; Wijetunge LS; Seidel VG; Harlow E; Wright AK; Bagni C; Contractor A; Gillingwater TH; Kind PC Hum Mol Genet; 2012 May; 21(10):2143-56. PubMed ID: 22328088 [TBL] [Abstract][Full Text] [Related]
55. Rescue of dendritic spine phenotype in Fmr1 KO mice with the mGluR5 antagonist AFQ056/Mavoglurant. Pop AS; Levenga J; de Esch CE; Buijsen RA; Nieuwenhuizen IM; Li T; Isaacs A; Gasparini F; Oostra BA; Willemsen R Psychopharmacology (Berl); 2014 Mar; 231(6):1227-35. PubMed ID: 23254376 [TBL] [Abstract][Full Text] [Related]
56. Analysis of FMR1 deletion in a subpopulation of post-mitotic neurons in mouse cortex and hippocampus. Amiri A; Sanchez-Ortiz E; Cho W; Birnbaum SG; Xu J; McKay RM; Parada LF Autism Res; 2014 Feb; 7(1):60-71. PubMed ID: 24408886 [TBL] [Abstract][Full Text] [Related]
58. Fragile X Mental Retardation Protein (FMRP) controls diacylglycerol kinase activity in neurons. Tabet R; Moutin E; Becker JA; Heintz D; Fouillen L; Flatter E; Krężel W; Alunni V; Koebel P; Dembélé D; Tassone F; Bardoni B; Mandel JL; Vitale N; Muller D; Le Merrer J; Moine H Proc Natl Acad Sci U S A; 2016 Jun; 113(26):E3619-28. PubMed ID: 27233938 [TBL] [Abstract][Full Text] [Related]
59. Abnormal presynaptic short-term plasticity and information processing in a mouse model of fragile X syndrome. Deng PY; Sojka D; Klyachko VA J Neurosci; 2011 Jul; 31(30):10971-82. PubMed ID: 21795546 [TBL] [Abstract][Full Text] [Related]
60. Delayed stabilization of dendritic spines in fragile X mice. Cruz-Martín A; Crespo M; Portera-Cailliau C J Neurosci; 2010 Jun; 30(23):7793-803. PubMed ID: 20534828 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]